Course Content
MODULE 3: 35 USC 102 & THE AIA
SECTION 3-1 : 35 USC 102 – Introduction
0/1
SECTION 5-1 : AIA Introduction
0/1
SECTION 5-2 : First Inventor To File
0/2
MODULE 5:AIA Focus Sections
SECTION 5-3 : AIA – Ethics and Practice Before the USPTO
0/1
SECTION 5-4 : AIA – Administrative Patent Trials
0/1
SECTION 5-5 : AIA – Best Mode
0/1
SECTION 5-6 : AIA – Citation of Patent Owner Statements Regarding Claim Scope
0/1
SECTION 5-7 : AIA – Covered Business Method Patents
0/1
SECTION 5-8 : AIA – Derivation Proceeding
0/1
SECTION 5-9 : AIA – Fees
0/1
SECTION 5-10 : Human Organisms
0/1
SECTION 5-11 : AIA – Inter Partes Re-Examination
0/1
SECTION 5-12 : AIA – Inter Partes Review
0/1
SECTION 5-13 : AIA – Inventors Oath
0/1
SECTION 5-14 : AIA – Micro Entities
0/1
SECTION 5-15 : AIA – Patent Prosecution Highway
0/1
SECTION 5-16 : AIA – Post Grant Review
0/1
SECTION 5-17 : AIA- Pre Issuance Submission
0/1
SECTION 5-18 : AIA – Prior User Rights Defense
0/1
SECTION 5-19 : AIA – Prioritized Exam
0/1
SECTION 5-20 : AIA – Supplemental Examination
0/1
SECTION 5-21 : AIA – Tax Strategies
0/1
01. AIA Study Suite

Human Organisms Overview

Objectives to know about Human Organisms specific to the AIA

  • Understand the AIA’s prohibition on patenting human organisms.
  • Identify the key laws and rules (37 CFR and 35 USC) pertaining to human organisms specific to the AIA.
  • Apply the laws and rules pertaining to human organisms specific to the AIA to real-world scenarios.

Key Laws and Rules (37 CFR and 35 USC) pertaining to Human Organisms specific to the AIA

  • 35 U.S.C. § 101: Definitions
  • 37 CFR § 1.101(d): Subject matter which is not patentable

Comprehensive, detailed, e-learning module content for Human Organisms specific to the AIA

Module 1: Introduction to the AIA’s prohibition on patenting human organisms

This module will introduce the AIA’s prohibition on patenting human organisms. It will discuss the rationale behind the prohibition, as well as the key laws and rules that pertain to human organisms specific to the AIA.

AIA’s prohibition on patenting human organisms

The AIA prohibits the patenting of human organisms as such. This prohibition is found in 35 U.S.C. § 101(d), which defines the term “patent or invention” to exclude “human organisms as such.”

Rationale behind the prohibition

The rationale behind the prohibition on patenting human organisms is that human organisms are not inventions. They are natural creations that are not the product of human ingenuity. Additionally, there are concerns that patenting human organisms could lead to the exploitation of human beings and could have negative ethical implications.

Key laws and rules

The key laws and rules that pertain to human organisms specific to the AIA are found in 35 U.S.C. § 101(d) and 37 CFR § 1.101(d).

Module 2: Applying the laws and rules pertaining to human organisms specific to the AIA to real-world scenarios

This module will discuss how to apply the laws and rules pertaining to human organisms specific to the AIA to real-world scenarios. It will cover common issues that arise in connection with the patentability of human organisms and how to address those issues.

Common issues

Some common issues that arise in connection with the patentability of human organisms include:

  • Whether a particular invention claims a human organism as such
  • Whether a particular invention claims a product or process that is inseparably bound to a human organism
  • Whether a particular invention claims a product or process that is derived from a human organism

Conclusion

The AIA’s prohibition on patenting human organisms is an important safeguard for human dignity and ethical values